
4-in-1 hormonal scalp formula addressing the multifactorial biology of female hair loss in a single nightly application.
No Insurance Required
Ships From USA Pharmacy
Free Medical Consultation
No Subscription Required
Licensed Provider
Licensed Pharmacy
HIPAA Compliant
LegitScript Certified







Yes. Women's Scalp Solution is a compounded prescription topical preparation requiring a valid prescription from a licensed healthcare provider. A telehealth consultation, hair loss evaluation, and hormone and health history review are required before dispensing to identify the cause of hair loss, confirm the appropriate active combination, and establish the treatment protocol.
Estradiol and progesterone: mild scalp irritation is most common. Rare systemic effects including breast tenderness, fluid retention, or mood changes may occur with significant absorption. Liothyronine: palpitations, tachycardia, or anxiety are possible if significant systemic absorption occurs, particularly in thyroid-sensitive patients. Azelaic acid: mild scalp tingling, warmth, or dryness in the first one to two weeks. Transient increased shedding in weeks 4-8 as follicles re-enter anagen is expected and temporary.
Women who are pregnant or may become pregnant should discuss all hair restoration actives with their provider, as certain agents (finasteride, spironolactone, and others) carry fetal risk. Patients with active scalp infections, significant inflammatory scalp conditions, or hypersensitivity to any prescribed active should not use this formulation until these conditions are evaluated. Those with a history of hormone-sensitive malignancy should have any hormonally active components reviewed with their oncologist before starting.
Patients on systemic HRT (oral or transdermal estradiol, progesterone) require coordinated provider management. Patients on any systemic thyroid medication (levothyroxine, desiccated thyroid, or liothyronine) require thyroid function monitoring and potential dose adjustment. Antithyroid medications (methimazole, propylthiouracil) may be partially counteracted. Beta-blockers and cardiovascular medications warrant disclosure due to the thyroid component.
Patients with thyroid disease, cardiovascular conditions, hormone-sensitive malignancy history, undiagnosed uterine bleeding, or liver impairment require individualized provider evaluation before starting. Lab monitoring including thyroid function and hormonal levels is recommended during treatment.
Licensed Provider
Licensed Pharmacy
HIPAA Compliant
LegitScript Certified

© 2026 TestosteroneShots.com, PC
text (323)-283-9219
638 1/2 N. Robertson Blvd, West Hollywood, CA 90069
The information and products provided on this website are for educational and wellness purposes only and are not intended to diagnose, treat, cure, or prevent any disease. All treatments require evaluation and approval by a licensed healthcare provider through a telemedicine consultation. Individual results may vary, and products carry potential risks and side effects. Certain products may not be evaluated by the U.S. Food and Drug Administration (FDA) unless explicitly stated. Services are provided by licensed physicians and nurse practitioners in states where they are authorized to practice, including California, Florida, Nevada, and other participating states. This service is not intended for medical emergencies. If you are experiencing an emergency, call 911 or seek immediate medical care. We take reasonable measures to protect personal health information in accordance with applicable privacy laws, including HIPAA. By using this website or its services, you agree to our Terms of Service, Privacy Policy, and Telehealth Consent. You must be 18 years of age or older to use this service. We do not manufacture, handle, or ship medications.



